27.12.2023.
Original Scientific Articles
Monitoring Adalimumab concentration, Adalimumab antibodies, fecal calprotectin, and QuantiFERON test positivity in patients with inflammatory bowel disease
Introduction. Inflammatory bowel diseases (IBD) are a serious global health problem affecting mostly younger and middle-aged persons. Despite the availability of variety of treatment approaches, the disease often progresses unpredictably. Biological drugs offer hope for IBD treatment. Our research share our preliminary findings regarding the monito...
By Goran Bokan, Tanja Glamočanin, Lana Mandić, Zoran Mavija